The LN18 GBM cells used in our study express S1P1, S1P2, S1P3 and S1P5 as well as SphK and therefore can be assumed as a suitable model for the investigation of S1P-mediated effects in GBM cells. The gene discussed is S1PR2; the disease is glioblastoma.